<em>BRCA</em>-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms
The discovery of <i>BRCA1</i> and <i>BRCA2</i> in the 1990s revolutionized the way we research and treat breast, ovarian, and pancreatic cancers. In the case of pancreatic cancers, germline mutations occur in about 10–20% of patients, with mutations in <i>BRCA1</i>...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/10/2453 |